Speakers

Meet Our Esteemed Speakers

Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.

Biomarkers Speakers

30 September - 01 October 2024 | Basel, Switzerland

Biomarkers Europe 2024

Amanda Heslegrave
Senior Research Fellow,
University College London
Brian Lockhart
Head of CDx,
Servier
Cornelia Wilson
Reader and Academic Laboratory Director,
Canterbury Christ Church University
Dirk Kemming
Medical Director Diagnostics Europe,
Daiichi Sankyo Europe
Ed Schuuring
Clinical Scientist in Molecular Pathology,
University Medical Center Groningen
Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis
Joanna Janus
Research Programme Manager,
Cancer Research UK
Marine Garrido
Global Translational Leader,
Bayer
Olga Nissan
Chief Executive Officer,
Protica Bio
Philip Beer
CSO,
Step Pharma
Shashank Saran
Associate Director,
AstraZeneca
Aitana Sogorb-Esteve
Senior Research Fellow,
University College London
Alain Van Gool
Professor Personalized Healthcare,
Radboud University Medical Center
Aliya Sarmanova
Clinical Development Lead Oncology & Genetics,
Roche
Andrew Janowczyk
Assistant Professor,
Emory University
Bernhard Reis
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
F. Hoffman-La Roche Ltd.
Christian Ruiz
Chief Scientific Officer,
University of Basel
Christophe Le Tourneau
Medical Oncologist,
Institut Curie
Dana Mustafa
Assistant Professor & Group Leader,
Erasmus MC
Daniel Keitley
Research Scientist,
Novo Nordisk
Dylan Powell
Assistant Professor in Public Health & Innovation,
Stirling University
Guillaume Desachy
Head Of Biometrics,
Pierre Fabre
Jacques Colinge
Professor,
University of Montpellier, France
Jan Christoph Brase
Global Translational Science Leader,
Bayer
Jehad Charo
Biomarker & Experimental Medicine Leader,
Hoffmann La Roche Ltd
Jun Frederiksen
Director,
Novo Nordisk
Malleswari Challagundla
Senior Scientist II,
AbbVie Deutschland GmbH & Co. KG
Maximilian Breitner
Lab Head Clinical Bioanalytics,
Sandoz
Mohammad Arastoo
Research Fellow,
University of Aberdeen/ TauRx Pharmaceuticals
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Sina Nassiri
Principal Bioinformatics Scientists & Team Lead,
Roche
Thomas Jensen
Chief Executive Officer,
Allarity Therapeutics
Vinko Tosevski
Senior Director Translational Research,
Immunos Therapeutics

28 - 29 October 2024 | San Diego, CA, USA

Biomarkers US 2024

Anand Giddabasappa
Head of Animal Models and Imaging,
Pfizer Inc
Arpita Ray
Principal Scientist,
Genentech
Jean-Francois Martini
Exec. Director, Translational Oncology Lead, Global Product Development - Oncology,
Pfizer
Kristina Mcguire
Executive Director and Head, Precision Medicine Laboratory Operations and Companion Diagnostics,
Regeneron
Kyuho Han
Chief Executive Officer,
MEDiC Life Sciences
Lokesh Agrawal
Program Director,
National Cancer Institute
Robert Getzenberg
Medical Director Diagnostics,
Astellas
Satya Saxena
Director, Global Proteomics, Clinical Pharmacology & Translational Medicine,
Eisai, Inc
Anshu Agrawal
Professor,
University of California, Irvine
Anuraag Shrivastav
President,
Oncodrex
David Weingeist
Scientific Director, Oncology Precision Medicine & Diagnostics,
Johnson & Johnson
Jadwiga Bienkowska
Senior Director,
Pfizer
Jonathan Sims
Senior Director,
Eli Lilly and Company
Joseph McDermott
Computational Biologist,
Lantern Pharma
KC Hart
Clinical Biomarker Lead,
IGM Biosciences
Manoj Kandpal
Director of Research Bioinformatics,
The Rockefeller University
Matthias von Herrath
Vice President & Senior Medical Officer, Global Chief Medical Office,
Novo Nordisk
Rawan Tarawneh
Associate Professor, School of Medicine, Department of Neurology,
University of New Mexico
Ruchi Gupta
Head of Biomarkers,
Alector Inc.
Soumya Poddar
Associate Director, Translational Sciences,
Gilead Sciences
Sripad Ram
Digital Pathology and Image Analysis Lead,
Pfizer Inc
Vitalay Fomin
Chief Executive Officer,
Numenos
Xuemei Zhao
Senior Principal Scientist,
Merck & Co., Inc.
Yiming Zhu
Senior Director, Biomarker Sciences,
Avidity Biosciences

30 September - 01 October 2025 | London, UK

Biomarkers 2025

Espen Walker
Global Head Medical Diagnostics,
AstraZeneca
Marcus Otte
Senior Director, Head of Clinical Biomarker and Technologies,
Merck Healthcare KGaA
Maria Orr
Head of Precision Medicine and Biosamples, Early Oncology,
AstraZeneca
Matt Brown
Chief Scientific Officer,
Genomics England
Professor Sir Mark Caulfield
Vice Principal for Health,
Queen Mary’s Faculty of Medicine and Dentistry
Sushma Iyengar
Senior Director, Global Regulatory Affairs, Precision Medicine & Digital Health,
Takeda
Svetlana Mukhina
Director Global Regulatory Affairs, Global Regulatory Affairs CDx,
Merck Group
Alain Van Gool
Professor Personalized Healthcare,
Radboud University Medical Center
Antonina Mitrofanova
Associate Professor and Associate Dean for Research,
Rutgers Health, SHP
Belinda Nedjai
Reader/ Associate Professor in cancer biomarker and Epigenetic,
Queen Mary University Of London
Chris Bray
Head Global Regulatory Affairs, Precision Medicine & Companion Diagnostics,
Merck Healthcare KGaA
Daniel Strasser
Director, Therapeutic Area Biomarker Lead / Biomarker Strategy Immunology,
Novartis
Emanuela Oldoni
Scientific Programme Manager- Biomarkers,
EATRIS
Emmanuel Valentin
Vice President, Translational Medicine,
Imcheck Therapeutics
Gayle Marshall
Head of Biomarkers,
Catapult Medicines Discovery
Giovanna Lalli
Director, Strategy & Operations,
LifeArc
Harpreet Saini
Senior Director Bioinformatics,
Astex Pharmaceuticals
Helen Graves
Principal Scientist,
Alchemab Therapeutics
Irene Del Molino del Barrio
Principal Scientist,
GSK
Jens Kieckbusch
Director, External Innovation Precision Medicine,
GlaxoSmithKline
Jim Eyles
Director, Clinical Immuno-Oncology Discovery Group,
AstraZeneca
Jimmy Bell
Professor,
University of Westminster
Jo Taylor
Founder,
METUPUK
Joanna Janus
Research Programme Manager,
Cancer Research UK
Johan Luthman
Executive Vice President & Head of Research & Development,
Lundbeck
Karl Smith-Byrne
Senior Molecular Epidemiologist,
Centre for Medicines Discovery
Katherine Freeman
Senior Portfolio Manager, Digital Health,
UK Research Councils
Kiri Granger
Chief Scientific Officer,
Monument Therapeutics
Laurent Audoly
CEO, Co-Founder,
PriveBio
Lindsay Darling
Director, Companion Diagnostics Portfolio Management & Operations,
Regeneron
Liz Harrington
Executive Director, Translational Medicine Global Head of Targeted Therapy Franchise (TDE),
ASTRAZENECA
Mani Mudaliar
Director, Quantitative Biomarkers,
Recursion
Manuela Cerina
Scientific Director of Neurodegeneration,
LifeArc
Maria Laura Garcia Bermejo
Scientific Director,
Ramon y Cajal Health Research Institute (IRYCIS)
Michael Zaiac
Head of Medical Affairs Oncology Region Europe,
Daiichi Sankyo
Michael Cannarile
Head of Oncology Biomarkers,
China Innovation Center of Roche
Mike Messenger
Head of Regulatory Strategy,
BIVDA
Miro Venturi
Operating Partner,
ARCHIMED
Nathalie Banner
Director of Ethics,
Genomics England
Neil Humphryes-Kirilov
Associate Director of Human Genomics,
C4X Discovery
Nitin Jain
Director, Franchise Project Management,
ASTRAZENECA
Olga Nissan
Chief Executive Officer,
Protica Bio
Peter Groenen
Head of Translational Science,
Cerebrum DAO
Roya Esat Dabestani
Precision Medicine Lead,
Innovate UK Business Connect
Thomas Jensen
Chief Executive Officer,
Allarity Therapeutics
Thomas Hach
Global Program Clinical Head,
Novartis
Valerie Taly
Group Leader,
University of Paris Descartes
Victoria Goss
Head of Early Diagnosis and Translational Group,
University of Southampton
Vihanga Pahalawatta
Director - Regulatory Affairs Companion Diagnostics,
AbbVie
Wanderson Dos Santos Trindade
Director Global Regulatory Affairs - Companion Diagnostics,
Daiichi-Sankyo